'Novo nordisk a s' diaporamas de présentation

Intro to Section 112: Enablement

684 views • 56 slides

Emergency Care Part 1: Managing Diabetic Ketoacidosis (DKA)

Emergency Care Part 1: Managing Diabetic Ketoacidosis (DKA). Slide no 2. Programme. Managing DKA. 1. 2. Treating and preventing hypoglycaemia. 3. Surgery in children with diabetes. Diabetic Ketoacidosis. Occurs when there is insufficient insulin action Commonly seen at diagnosis

783 views • 40 slides

Routine Care

Routine Care. Principles of care. 1. 2. Insulin therapy. 3. Blood glucose testing. 4. Dietary advice. 5. Use of HbA1c. 6. Quality of care indicators. Programme. Monitoring growth in childhood. 7. Principles of Care. Goals of care include: Eradicate symptoms.

743 views • 39 slides

Hatch Waxman: Prescriptions for Innovative and Inexpensive Medicines The Generic Perspective May 7, 2010

AIPLA. Hatch Waxman: Prescriptions for Innovative and Inexpensive Medicines The Generic Perspective May 7, 2010. Purpose of the Hatch-Waxman Act.

610 views • 36 slides

Enablement and Written Description

542 views • 35 slides

Diagnosing diabetes in Childhood

Diagnosing diabetes in Childhood. Programme. Suspecting diabetes. 1. 2. Confirming the diagnosis. Suspecting diabetes. Presentation title. Diabetes in childhood. How does diabetes in children develop?

355 views • 25 slides

Coping with Diabetes

Coping with Diabetes. Programme. What to tell the family. 1. School issues. 7. 2. Dispelling myths and false beliefs. 8. Exercise. 3. Acute illness. 9. Smoking, alcohol and drugs. 4. Nutritional advice. 10. Pregnancy. 5. Storing insulin. 11. Fasting. 6.

613 views • 24 slides

Chronic Care Plan

Chronic Care Plan. Programme. Long-term complications. 1. 2. Co-morbid conditions. Long-term complications. Slide no 4. Complications. Eyes (retinopathy) ? blindness Also cataracts Kidneys (nephropathy) ? kidney failure Nerves (neuropathy) ? decreased pain perception Blood vessels

343 views • 24 slides

Coping with Diabetes

Coping with Diabetes. Programme. What to tell the family. 1. School issues. 7. 2. Dispelling myths and false beliefs. 8. Exercise. 3. Acute illness. 9. Smoking, alcohol and drugs. 4. Nutritional advice. 10. Pregnancy. 5. Storing insulin. 11. Fasting. 6.

339 views • 24 slides

Juicy Whip, Inc. v. Orange Bang, Inc. , 51 U.S.P.Q.2d 1700 (Fed.Cir. 1999)

457 views • 24 slides

Women in Leadership - Get fact based

Women in Leadership - Get fact based. Elin Schmidt Vice President Ethics & Social Responsibility Novo Nordisk A/S. Diversity in Novo Nordisk. Our position. Women in Leadership: A European Business Imperative. Personal Profiles, by Gender. Women. Men. 43. Age (in years). 50. 75%.

381 views • 18 slides

Prosecution Group Luncheon Patents

Prosecution Group Luncheon Patents. July, 2011. Inequitable Conduct Post- Therasense. American Calcar, Inc. v. American Honda Motor Co. (FC 2011) Inventors examined car navigation system having similar features Background discussion of PA system left out user-interface aspect

185 views • 5 slides

A Population PK/PD Model Assessing the Pharmacodynamics of a Rapid-acting Recombinant FVIIa Analogue, NN1731, in Healthy

V 2. B ? k out ? (1+ E ? C p ). Q. V 1. NN1731 dose. , ,.. Model predictions (individual) Model predictions (typical subject) o , o ,.. Observations + Mean of observations at time point. NN1731 effect. C p. F 1+2. CL. k out.

428 views • 1 slides